{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:44:51Z","timestamp":1782492291536,"version":"3.54.5"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s11882-017-0680-7","type":"journal-article","created":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T03:04:49Z","timestamp":1487905489000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Chikungunya Infection: a Global Public Health Menace"],"prefix":"10.1007","volume":"17","author":[{"given":"A. J.","family":"Mathew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ganapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Kabeerdoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Chebbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. K.","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debashish","family":"Danda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,24]]},"reference":[{"key":"680_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/0035-9203(55)90080-8","volume":"49","author":"MC Robinson","year":"1955","unstructured":"Robinson MC. An epidemic of virus disease in Southern Province, Tanganyika Territory in 1952\u201353\u20141: clinical features. Trans R Soc Trop Med Hyg. 1955;49:28.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"680_CR2","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.antiviral.2013.06.009","volume":"99","author":"SD Thiberville","year":"2013","unstructured":"Thiberville SD, Moyen N, Dupuis-Maguiraga L, et al. Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy. Antivir Res. 2013;99:345\u201370.","journal-title":"Antivir Res"},{"key":"680_CR3","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1007\/s10067-016-3390-y","volume":"35","author":"C Pineda","year":"2016","unstructured":"\u2022 Pineda C, Munoz-Louis R, Caballero-Uribe CV, Viasus D. Chikungunya in the region of the Americas. A challenge for rheumatologists and health care systems. Clin Rheumatol. 2016;35:2381\u20135. A comprehensive review on the clinical features of CHIKV in the American continent, and also emphasizing on the challenges to the healthcare system following the epidemic.","journal-title":"Clin Rheumatol"},{"key":"680_CR4","unstructured":"Centers for Disease Control and Prevention: Chikungunya virus http:\/\/www.cdc.gov\/chikungunya\/geo\/united-states.html (Accessed Oct 12, 2016)"},{"key":"680_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002137","volume":"7","author":"C Schilte","year":"2013","unstructured":"\u2022\u2022 Schilte C, Staikowsky F, Couderc T, et al. Chikungunya virus-associated long-term arthralgia: a 36 month prospective longitudinal study. PLoS Negl Trop Dis. 2013;7, e2137. doi:10.1371\/journal.pntd.0002137. A 3-year post-infection study of patients affected by CHIKV during the 2006 La Reunion island epidemic in France, describing 60% of the patients complaining of arthralgia during the follow up period, emphasizing the relatively high frequency of chronic complications following acute infection.","journal-title":"PLoS Negl Trop Dis"},{"key":"680_CR6","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1111\/j.1742-1241.2011.02792.x","volume":"65","author":"AJ Mathew","year":"2011","unstructured":"Mathew AJ, Goyal V, George E, Thekkemuriyil DV, Jayakumar B, Chopra A. Rheumatic-musculoskeletal pain and disorders in a na\u00efve group of individuals 15 months following a Chikungunya viral epidemic in south India: a population based observational study. Int J Clin Pract. 2011;65:1306\u201312.","journal-title":"Int J Clin Pract"},{"key":"680_CR7","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1002\/acr.22900","volume":"68","author":"AJ Rodriguez-Morales","year":"2016","unstructured":"Rodriguez-Morales AJ, Cardona-Ospina JA, Urbano-Garzon SF, Hurtado-Zapata JS. Prevalence of post-chikungunya infection chronic inflammatory arthritis: a systemic review and meta-analysis. Arthritis Care Res. 2016;68:1849\u201358.","journal-title":"Arthritis Care Res"},{"key":"680_CR8","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3855\/jidc.169","volume":"3","author":"F Cavrini","year":"2009","unstructured":"Cavrini F, Gaibani P, Pierro AM, Rossini G, Landini MP, Sambri V. Chikungunya: an emerging and spreading arthropod-borne viral disease. J Infect Dev Ctries. 2009;3:744\u201352.","journal-title":"J Infect Dev Ctries"},{"key":"680_CR9","doi-asserted-by":"publisher","first-page":"6294","DOI":"10.1128\/JVI.00370-14","volume":"88","author":"A Vega-R\u00faa","year":"2014","unstructured":"Vega-R\u00faa A, Zouache K, Girod R, Failloux A-B, Louren\u00e7o-de-Oliveira R. High level of vector competence of Aedes aegypti and Aedes albopictus from ten American countries as a crucial factor in the spread of chikungunya virus. J Virol. 2014;88:6294\u2013306.","journal-title":"J Virol"},{"key":"680_CR10","doi-asserted-by":"crossref","unstructured":"\u2022 Ng LC, Hapuarachchi HC. Tracing the path of Chikungunya virus-evolution and adaptation. Infect Genet Evol. 2010;10:876\u201385. In this explicit review, the authors explain the biologically important E1-A226V and E2-I211T mutations undergone by CHIK virus, which resulted in the change in epidemiology of infection as a result of rapid adaptation to the \n                              Aedes albopictus \n                              vector. The role of environmental factors and preemptive methods for combating the disease are emphasized.","DOI":"10.1016\/j.meegid.2010.07.012"},{"key":"680_CR11","first-page":"151","volume":"43","author":"C Lahariya","year":"2006","unstructured":"Lahariya C, Pradhan SK. Emergence of chikungunya virus in Indian subcontinent after 32 years: a review. J Vector Borne Dis. 2006;43:151\u201360.","journal-title":"J Vector Borne Dis"},{"key":"680_CR12","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.3201\/eid1908.121739","volume":"19","author":"H Savini","year":"2013","unstructured":"Savini H, Gautret P, Gaudart J, et al. Travel-associated diseases, Indian Ocean Islands, 1997\u20132010. Emerg Infect Dis. 2013;19:1297\u2013301.","journal-title":"Emerg Infect Dis"},{"key":"680_CR13","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1016\/S0140-6736(07)61779-6","volume":"370","author":"G Rezza","year":"2007","unstructured":"Rezza G, Nicoletti L, Angelini R, et al. Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet Lond Engl. 2007;370:1840\u20136.","journal-title":"Lancet Lond Engl"},{"key":"680_CR14","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1111\/j.1469-0691.2010.03386.x","volume":"16","author":"EA Gould","year":"2010","unstructured":"Gould EA, Gallian P, De Lamballerie X, Charrel RN. First cases of autochthonous dengue fever and chikungunya fever in France: from bad dream to reality! Clin Microbiol Infect. 2010;16:1702\u20134.","journal-title":"Clin Microbiol Infect"},{"key":"680_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.reuma.2014.07.005","volume":"11","author":"ML Horcada","year":"2015","unstructured":"Horcada ML, D\u00edaz-Calder\u00f3n C, Garrido L. Chikungunya fever. Rheumatic manifestations of an emerging disease in Europe. Reumatol Clin. 2015;11:161\u20134.","journal-title":"Reumatol Clin"},{"key":"680_CR16","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.coviro.2011.07.004","volume":"1","author":"KA Tsetsarkin","year":"2011","unstructured":"Tsetsarkin KA, Chen R, Sherman MB, Weaver SC. Chikungunya virus: evolution and genetic determinants of emergence. Curr Opin Virol. 2011;1:310\u20137.","journal-title":"Curr Opin Virol"},{"key":"680_CR17","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S1473-3099(06)70531-X","volume":"6","author":"P Reiter","year":"2006","unstructured":"Reiter P, Fontenille D, Paupy C. Aedes albopictus as an epidemic vector of chikungunya virus: another emerging problem? Lancet Infect Dis. 2006;6:463\u20134.","journal-title":"Lancet Infect Dis"},{"key":"680_CR18","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1099\/vir.0.82858-0","volume":"88","author":"AM Powers","year":"2007","unstructured":"Powers AM, Logue CH. Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus. J Gen Virol. 2007;88:2363\u201377.","journal-title":"J Gen Virol"},{"key":"680_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0030201","volume":"3","author":"KA Tsetsarkin","year":"2007","unstructured":"Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S. A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog. 2007;3, e201.","journal-title":"PLoS Pathog"},{"key":"680_CR20","first-page":"45","volume":"47","author":"P Yadav","year":"2003","unstructured":"Yadav P, Gokhale MD, Barde PV, Singh DK, Mishra AC, Mourya DT. Experimental transmission of Chikungunya virus by Anopheles stephensi mosquitoes. Acta Virol. 2003;47:45\u20137.","journal-title":"Acta Virol"},{"key":"680_CR21","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S1995-7645(14)60164-4","volume":"7","author":"A Lo Presti","year":"2014","unstructured":"Lo Presti A, Lai A, Cella E, Zehender G, Ciccozzi M. Chikungunya virus, epidemiology, clinics and phylogenesis: a review. Asian Pac J Trop Med. 2014;7:925\u201332.","journal-title":"Asian Pac J Trop Med"},{"key":"680_CR22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4269\/ajtmh.1999.60.281","volume":"60","author":"M Diallo","year":"1999","unstructured":"Diallo M, Thonnon J, Traore-Lamizana M, Fontenille D. Vectors of Chikungunya virus in Senegal: current data and transmission cycles. Am J Trop Med Hyg. 1999;60:281\u20136.","journal-title":"Am J Trop Med Hyg"},{"key":"680_CR23","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.3201\/eid1210.060610","volume":"12","author":"P Parola","year":"2006","unstructured":"Parola P, de Lamballerie X, Jourdan J, et al. Novel chikungunya virus variant in travelers returning from Indian Ocean islands. Emerg Infect Dis. 2006;12:1493\u20139.","journal-title":"Emerg Infect Dis"},{"key":"680_CR24","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3201\/eid2207.160116","volume":"22","author":"G Simmons","year":"2016","unstructured":"Simmons G, Br\u00e8s V, Lu K, et al. High incidence of chikungunya virus and frequency of viremic blood donations during epidemic, Puerto Rico, USA, 2014. Emerg Infect Dis. 2016;22:1221\u20138.","journal-title":"Emerg Infect Dis"},{"key":"680_CR25","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1093\/infdis\/jis296","volume":"206","author":"T Couderc","year":"2012","unstructured":"Couderc T, Gangneux N, Chr\u00e9tien F, et al. Chikungunya virus infection of corneal grafts. J Infect Dis. 2012;206:851\u20139.","journal-title":"J Infect Dis"},{"key":"680_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050060","volume":"5","author":"P G\u00e9rardin","year":"2008","unstructured":"G\u00e9rardin P, Barau G, Michault A, et al. Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La R\u00e9union. PLoS Med. 2008;5, e60.","journal-title":"PLoS Med"},{"key":"680_CR27","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s12026-012-8266-x","volume":"53","author":"TH Teo","year":"2012","unstructured":"Teo TH, Lum FM, Lee WW, Ng LF. Mouse models for Chikungunya virus: deciphering immune mechanisms responsible for disease and pathology. Immunol Res. 2012;53:136\u201347.","journal-title":"Immunol Res"},{"key":"680_CR28","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1172\/JCI40104","volume":"120","author":"K Labadie","year":"2010","unstructured":"Labadie K, Larcher T, Joubert C, et al. Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J Clin Invest. 2010;120:894\u2013906.","journal-title":"J Clin Invest"},{"key":"680_CR29","doi-asserted-by":"publisher","first-page":"8021","DOI":"10.1128\/JVI.02603-09","volume":"84","author":"J Gardner","year":"2010","unstructured":"Gardner J, Anraku I, Le TT, et al. Chikungunya virus arthritis in adult wild-type mice. J Virol. 2010;84:8021\u201332.","journal-title":"J Virol"},{"key":"680_CR30","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ajpath.2010.11.018","volume":"178","author":"TE Morrison","year":"2011","unstructured":"Morrison TE, Oko L, Montogomery SA, et al. A mouse model of Chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis and persistence. Am J Pathol. 2011;178:32\u201340.","journal-title":"Am J Pathol"},{"key":"680_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0040029","volume":"4","author":"T Couderc","year":"2008","unstructured":"\u2022 Couderc T, Chretien F, Schilte C, et al. A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog. 2008;4, e29. One of the initial bench side animal model research in CHIK virus, highlighting the role of type-I interferon signaling in severe disease.","journal-title":"PLoS Pathog"},{"key":"680_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0155243","volume":"16","author":"BA Goupil","year":"2016","unstructured":"Goupil BA, McNulty MA, Martin MJ, McCracken MK, Christofferson RC, Mores CN. Novel lessons of bones and joints associated with Chikungunya virus infection in two mouse models of disease: new insights into disease pathogenesis. PLoS One. 2016;16, e0155243.","journal-title":"PLoS One"},{"key":"680_CR33","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1084\/jem.20090851","volume":"207","author":"C Schilte","year":"2010","unstructured":"Schilte C, Couderc T, Chretien F, et al. Type I IFN controls chikungunya virus via its action on nonhematopoietic cells. J Exp Med. 2010;207:429\u201342.","journal-title":"J Exp Med"},{"key":"680_CR34","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/infdis\/jir470","volume":"204","author":"NE Rulli","year":"2011","unstructured":"\u2022 Rulli NE, Rolph MS, Srikiatkhachorn A, Anantapreecha S, Guglielmotti A, Mahalingam S. Protection from arthritis and myositis in a mouse model of acute chikungunya virus disease by bindarit, an inhibitor of monocyte chemotactic protein-1 synthesis. J Infect Dis. 2011;204:1026\u201330. In this study, the authors have demonstrated the presence of cytokines in a mouse model of CHIKV arthritis and myositis. The role of chemokine MCP-1 and its inhibitor bindarit ameliorating the disease in mice is also studied. This has a potential for a future drug target.","journal-title":"J Infect Dis"},{"key":"680_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111305","volume":"24","author":"A Venugopalan","year":"2014","unstructured":"Venugopalan A, Ghorpade RP, Chopra A. Cytokines in acute Chikungunya. PLoS One. 2014;24, e111305.","journal-title":"PLoS One"},{"key":"680_CR36","doi-asserted-by":"publisher","first-page":"7955","DOI":"10.1128\/JVI.00909-15","volume":"89","author":"TH Teo","year":"2015","unstructured":"Teo TH, Her Z, Tan JJ, et al. Caribbean and La Reunion Chikungunya virus isolates differ in their capacity to induce proinflammatory Th1 and NK cell responses and acute joint pathology. J Virol. 2015;89:7955\u201369.","journal-title":"J Virol"},{"key":"680_CR37","doi-asserted-by":"publisher","first-page":"259","DOI":"10.4049\/jimmunol.1202177","volume":"190","author":"TH Teo","year":"2013","unstructured":"Teo TH, Lum FM, Claser C, et al. A pathogenic role of CD4+ T cells during Chikungunya virus infection in mice. J Immunol. 2013;190:259\u201369.","journal-title":"J Immunol"},{"key":"680_CR38","doi-asserted-by":"publisher","first-page":"6295","DOI":"10.4049\/jimmunol.1300304","volume":"190","author":"FM Lum","year":"2013","unstructured":"Lum FM, Teo TH, Lee WW, Kam YW, Renia L, Ng LF. An essential role of antibodies in the control of Chikungunya virus infection. J Immunol. 2013;190:6295\u2013302.","journal-title":"J Immunol"},{"key":"680_CR39","doi-asserted-by":"publisher","first-page":"13005","DOI":"10.1128\/JVI.01780-12","volume":"86","author":"YW Kam","year":"2012","unstructured":"Kam YW, Lee WW, Simarmata D, et al. Longitudinal analysis of the human antibody response to Chikungunya virus infection: implications for serodiagnosis and vaccine development. J Virol. 2012;86:13005\u201315.","journal-title":"J Virol"},{"key":"680_CR40","doi-asserted-by":"publisher","first-page":"5914","DOI":"10.4049\/jimmunol.0900255","volume":"184","author":"JJ Hoarau","year":"2010","unstructured":"\u2022\u2022 Hoarau JJ, Jaffar Bandjee MC, Krejbich Trotot P, et al. Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response. J Immunol. 2010;184:5914\u201327. A well-designed study analyzing the factors responsible for chronic complications in the La Reunion island epidemic in 2006. In a prospective cohort of 49 patients, categorized into two distinct groups\u2014recovered or chronic, 12\u00a0months post-infection, the authors describe contrasting cellular and molecular events, focusing on drug targets.","journal-title":"J Immunol"},{"key":"680_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004499","volume":"10","author":"C Petitdemange","year":"2016","unstructured":"Petitdemange C, Wauquier N, Devilliers H, et al. Longitudinal analysis of natural killer cells in dengue virus-infected patients in comparison to chikungunya and chikungunya\/dengue virus-infected patients. PLoS Negl Trop Dis. 2016;10, e0004499.","journal-title":"PLoS Negl Trop Dis"},{"key":"680_CR42","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/infdis\/jis368","volume":"206","author":"M Noret","year":"2012","unstructured":"Noret M, Herrero L, Rulli N, et al. Interleukin 6, RANKL, and osteoprotegerin expression by chikungunya virus-infected human osteoblasts. J Infect Dis. 2012;206:455\u20137.","journal-title":"J Infect Dis"},{"key":"680_CR43","doi-asserted-by":"publisher","first-page":"6040","DOI":"10.1073\/pnas.1318859111","volume":"111","author":"W Chen","year":"2014","unstructured":"\u2022 Chen W, Foo SS, Rulli NE, et al. Arthritogenic alphaviral infection pertubs osteoblast function and triggers pathologic bone loss. Proc Natl Acad Sci U S A. 2014;111:6040\u20135. A study describing the pathogenesis of bone loss caused by alphaviruses. In Ross River virus-infected human osteoblasts, the authors demonstrated higher levels of inflammatory cytokines and disrupted ratio of RANK\/OPG.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"680_CR44","doi-asserted-by":"publisher","first-page":"5767","DOI":"10.1073\/pnas.1404206111","volume":"111","author":"KD Ryman","year":"2014","unstructured":"Ryman KD, Klimstra WB. Closing the gap between viral and noninfectious arthritis. Proc Natl Acad Sci U S A. 2014;111:5767\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"680_CR45","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.mcna.2008.07.008","volume":"92","author":"F Simon","year":"2008","unstructured":"Simon F, Savini H, Parola P. Chikungunya: a paradigm of emergence and globalization of vector-borne diseases. Med Clin North Am. 2008;92:1323\u201343.","journal-title":"Med Clin North Am"},{"key":"680_CR46","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S1473-3099(07)70107-X","volume":"7","author":"G Pialoux","year":"2007","unstructured":"Pialoux G, Ga\u00fcz\u00e8re B-A, Jaur\u00e9guiberry S, Strobel M. Chikungunya, an epidemic arbovirosis. Lancet Infect Dis. 2007;7:319\u201327.","journal-title":"Lancet Infect Dis"},{"key":"680_CR47","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.3201\/eid1210.060610","volume":"12","author":"P Parola","year":"2006","unstructured":"Parola P, de Lamballerie X, Jourdan J, Rovery C, Vaillant V, Minodier P, et al. Novel Chikungunya virus variant in travelers returning from Indian Ocean islands. Emerg Infect Dis. 2006;12:1493\u20139.","journal-title":"Emerg Infect Dis"},{"key":"680_CR48","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1086\/518701","volume":"45","author":"W Taubitz","year":"2007","unstructured":"Taubitz W, Cramer JP, Kapaun A, Pfeffer M, Drosten C, Dobler G, et al. Chikungunya fever in travelers: clinical presentation and course. Clin Infect Dis. 2007;45:e1\u20134.","journal-title":"Clin Infect Dis"},{"key":"680_CR49","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1086\/517537","volume":"44","author":"G Borgherini","year":"2007","unstructured":"\u2022 Borgherini G, Poubeau P, Staikowsky F, Lory M, Le Moullec N, Becquart JP, et al. Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients. Clin Infect Dis. 2007;44:1401\u20137. In one of the early analyses of the 2005\u201306 La Reunion island epidemics in France, the authors describe the demography, clinical features, and laboratory parameters of 157 affected patients.","journal-title":"Clin Infect Dis"},{"key":"680_CR50","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1869-5760-3-35","volume":"3","author":"P Mahendradas","year":"2013","unstructured":"Mahendradas P, Avadhani K, Shetty R. Chikungunya and the eye: a review. J Ophthalmic Inflamm Infect. 2013;3:35.","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"680_CR51","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ijid.2016.09.009","volume":"51","author":"JR Torres","year":"2016","unstructured":"\u2022 Torres JR, Falleiros-Arlant LH, Duenas L, Pleitez-Nevarrete J, Salgado DM, Castillo JB. Congenintal and perinatal complications of chikungunya fever: a Latin American experience. Int J Infect Dis. 2016;51:85\u20138. A prospective study of 169 symptomatic newborns in Latin America during the 2014\u20132015 CHIKV epidemic. Clinical features, complications, and vertical transmission rates are described. The authors have also analyzed pregnancy outcomes in symptomatic infected mothers.","journal-title":"Int J Infect Dis"},{"key":"680_CR52","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jcv.2010.07.004","volume":"49","author":"MK Win","year":"2010","unstructured":"Win MK, Chow A, Dimatatac F, Go CJ, Leo YS. Chikungunya fever in Singapore: acute clinical and laboratory features, and factors associated with persistent arthralgia. J Clin Virol. 2010;49:111\u20134.","journal-title":"J Clin Virol"},{"key":"680_CR53","doi-asserted-by":"publisher","first-page":"R9","DOI":"10.1186\/ar4137","volume":"15","author":"P G\u00e9rardin","year":"2013","unstructured":"G\u00e9rardin P, Fianu A, Michault A, et al. Predictors of Chikungunya rheumatism: a prognostic survey ancillary to the TELECHIK cohort study. Arthritis Res Ther. 2013;15:R9.","journal-title":"Arthritis Res Ther"},{"key":"680_CR54","first-page":"83","volume":"72","author":"A Rib\u00e9ra","year":"2012","unstructured":"Rib\u00e9ra A, Degasne I, Jaffar Bandjee MC, Gasque P. Chronic rheumatic manifestations following chikungunya virus infection: clinical description and therapeutic considerations. Med Trop. 2012;72:83\u20135.","journal-title":"Med Trop"},{"key":"680_CR55","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jbspin.2009.08.005","volume":"76","author":"E Bouquillard","year":"2009","unstructured":"Bouquillard E, Combe B. A report of 21 cases of rheumatoid arthritis following chikungunya fever. A mean follow-up of two years. Joint Bone Spine. 2009;76:654\u20137.","journal-title":"Joint Bone Spine"},{"issue":"Suppl3","key":"680_CR56","first-page":"567","volume":"70","author":"AJ Mathew","year":"2011","unstructured":"Mathew AJ, Chopra A, Antony J, Anandan N, Nair GS. Increased incidence of soft tissue rheumatism following Chikungunya viral epidemic: incidental or cause? Ann Rheum Dis. 2011;70(Suppl3):567.","journal-title":"Ann Rheum Dis"},{"key":"680_CR57","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1177\/0961203314531637","volume":"23","author":"P Nelson","year":"2014","unstructured":"Nelson P, Rylance P, Roden D, Trela M, Tugnet N. Viruses as potential pathogenic agents in systemic lupus erythematosus. Lupus. 2014;23:596\u2013605.","journal-title":"Lupus"},{"key":"680_CR58","first-page":"1831","volume":"23","author":"JH Vaughan","year":"1996","unstructured":"Vaughan JH. Viruses and autoimmune disease. J Rheumatol. 1996;23:1831\u20133.","journal-title":"J Rheumatol"},{"key":"680_CR59","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.trstmh.2010.01.011","volume":"104","author":"SP Manimunda","year":"2010","unstructured":"Manimunda SP, Vijayachari P, Uppoor R, et al. Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging. Trans R Soc Trop Med Hyg. 2010;104:392\u201399.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"680_CR60","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1136\/postgradmedj-2012-131477","volume":"89","author":"K Essackjee","year":"2013","unstructured":"Essackjee K, Goorah S, Ramchurn SK, Cheeneebash J, Walker-Bone K. Prevalence of and risk factors for chronic arthralgia and rheumatoid-like polyarthritis more than 2 years after infection with chikungunya virus. Postgrad Med J. 2013;89:440\u20137.","journal-title":"Postgrad Med J"},{"key":"680_CR61","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1002\/art.23753","volume":"58","author":"A Chopra","year":"2008","unstructured":"Chopra A, Anuradha V, Lagoo-Joshi V, Kunjir V, Salvi S, Saluja M. Chikungunya virus aches and pains: an emerging challenge. Arthritis Rheum. 2008;58:2921\u20132.","journal-title":"Arthritis Rheum"},{"key":"680_CR62","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1128\/CVI.00720-14","volume":"22","author":"HE Prince","year":"2015","unstructured":"Prince HE, Seaton BL, Matud JL, Batterman HJ. Chikungunya virus RNA and antibody testing at a national reference laboratory since the emergence of Chikungunya virus in the Americas. Clin Vaccine Immunol. 2015;22:291\u20137.","journal-title":"Clin Vaccine Immunol"},{"key":"680_CR63","doi-asserted-by":"publisher","first-page":"e0004953","DOI":"10.1371\/journal.pntd.0004953","volume":"10","author":"P Patel","year":"2016","unstructured":"Patel P, Abd El Wahed A, Faye O, et al. A field-deployable reverse transcription recombinase polymerase amplification assay for rapid detection of the Chikungunya virus. PLoS Negl Trop Dis. 2016;10:e0004953.","journal-title":"PLoS Negl Trop Dis"},{"key":"680_CR64","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1128\/JCM.01734-06","volume":"45","author":"MM Parida","year":"2007","unstructured":"Parida MM, Santhosh SR, Dash PK, et al. Rapid and real-time detection of Chikungunya virus by reverse transcription loop-mediated isothermal amplification assay. J Clin Microbiol. 2007;45:351\u20137.","journal-title":"J Clin Microbiol"},{"key":"680_CR65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004261","volume":"4","author":"LFP Ng","year":"2009","unstructured":"Ng LFP, Chow A, Sun J, Dwek DJC, et al. IL-1\u03b2, IL-6 and RANTES as biomarkers of Chikungunya severity. PLoS One. 2009;4, e4261.","journal-title":"PLoS One"},{"key":"680_CR66","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S1995-7645(13)60108-X","volume":"6","author":"C Chirathworn","year":"2013","unstructured":"Chirathworn C, Poovorawan Y, Lertmaharit S, Wuttirattanakowit N. Cytokine levels in patients with Chikungunya virus infection. Asian Pac J Trop Med. 2013;6:631\u20134.","journal-title":"Asian Pac J Trop Med"},{"key":"680_CR67","first-page":"217","volume":"66","author":"SW Brighton","year":"1984","unstructured":"Brighton SW. Chloroquine phosphate treatment of chronic Chikungunya arthritis. An open pilot study. South Afr Med J. 1984;66:217\u20138.","journal-title":"South Afr Med J"},{"key":"680_CR68","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/art.38221","volume":"66","author":"A Chopra","year":"2014","unstructured":"Chopra A, Saluja M, Venugopalan A. Effectiveness of chloroquine and inflammatory cytokine response in patients with early persistent musculoskeletal pain and arthritis following chikungunya virus infection. Arthritis Rheumatol. 2014;66:319\u201326.","journal-title":"Arthritis Rheumatol"},{"key":"680_CR69","doi-asserted-by":"crossref","unstructured":"\u2022 Ravindran V, Alias G. Efficacy of combination DMARD therapy vs hydroxychloroquine monotherapy in chronic persistent chikungunya arthritis: a 24-week randomized controlled open label study. Clin Rheumatol 2016. A randomized control trial of combination DMARDs vs HCQ monotherapy in 72 patients with chronic CHIKV rheumatism, showing better efficacy with combination therapy","DOI":"10.1007\/s10067-016-3429-0"},{"key":"680_CR70","first-page":"83","volume":"59","author":"MA Ganu","year":"2011","unstructured":"Ganu MA, Ganu AS. Post-chikungunya chronic arthritis\u2014our experience with DMARDs over two year follow up. J Assoc Physicians India. 2011;59:83\u20136.","journal-title":"J Assoc Physicians India"},{"key":"680_CR71","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3855\/T2.2.140","volume":"2","author":"R Ravichandran","year":"2008","unstructured":"Ravichandran R, Manian M. Ribavirin therapy for Chikungunya arthritis. J Infect Dev Ctries. 2008;2:140\u20132.","journal-title":"J Infect Dev Ctries"},{"key":"680_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002586","volume":"8","author":"BM Gunn","year":"2012","unstructured":"Gunn BM, Morrison TE, Whitmore AC, et al. Mannose binding lectin is required for alphavirus-induced arthritis\/myositis. PLoS Pathog. 2012;8, e1002586.","journal-title":"PLoS Pathog"},{"key":"680_CR73","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nature11866","volume":"494","author":"S Shoji-Kawata","year":"2013","unstructured":"Shoji-Kawata S, Sumpter R, Leveno M, Campbell GR, Zou Z, Kinch L, et al. Identification of a candidate therapeutic autophagy-inducing peptide. Nature. 2013;494:201\u20136.","journal-title":"Nature"},{"key":"680_CR74","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.medmal.2015.05.007","volume":"45","author":"F Simon","year":"2015","unstructured":"\u2022 Simon F, Javelle E, Cabie A, et al. French guidelines for management of chikungunya (acute and persistent presentations), November 2014. Med Mal Infect. 2015;45:243\u201363. First published guidelines for diagnosis, assessment, and management of acute, post-acute, and chronic CHIKV.","journal-title":"Med Mal Infect"},{"key":"680_CR75","doi-asserted-by":"publisher","unstructured":"Wang YM, Lu JW, Lin CC, et al. Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission. Antiviral Res 2016. doi: 10.1016\/j.antiviral.2016.10.003","DOI":"10.1016\/j.antiviral.2016.10.003"},{"key":"680_CR76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0133511","volume":"10","author":"YJ Ho","year":"2015","unstructured":"Ho YJ, Wang YM, Lu JW, et al. Suramin inhibits Chikungunya virus entry and transmission. PLoS One. 2015;10, e0133511. doi:10.1371\/journal.pone.0133511.","journal-title":"PLoS One"},{"key":"680_CR77","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12985-016-0607-2","volume":"13","author":"L Hen\u03b2","year":"2016","unstructured":"Hen\u03b2 L, Beck S, Weidner T, et al. Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry. Virol J. 2016;13:149.","journal-title":"Virol J"},{"key":"680_CR78","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.antiviral.2016.07.025","volume":"134","author":"SC Kuo","year":"2016","unstructured":"Kuo SC, Wang YM, Ho YJ, et al. Suramin treatment reduces chikungunya pathogenesis in mice. Antiviral Res. 2016;134:89\u201396.","journal-title":"Antiviral Res"},{"key":"680_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2014.05.004","volume":"108","author":"A Dagley","year":"2014","unstructured":"Dagley A, Ennis J, Turner JD, et al. Protection against Chikungunya virus induced arthralgia following prophylactic treatment with adenovirus vectored interferon (mDEF201). Antiviral Res. 2014;108:1\u20139.","journal-title":"Antiviral Res"},{"key":"680_CR80","unstructured":"Prevention | Chikungunya virus | CDC [Internet]. [cited 2016 Jun 23]. Available from: http:\/\/www.cdc.gov\/chikungunya\/prevention\/"},{"key":"680_CR81","unstructured":"Protection against Mosquitoes, Ticks, & Other Arthropods - Chapter 2\u20132016 Yellow Book | Travelers\u2019 Health | CDC [Internet]. [cited 2016 Jun 23]. Available from: http:\/\/wwwnc.cdc.gov\/travel\/yellowbook\/2016\/the-pre-travel-consultation\/protection-against-mosquitoes-ticks-other-arthropods"},{"key":"680_CR82","unstructured":"WHO | Control strategies [Internet]. WHO. [cited 2016 Jun 23]. Available from: http:\/\/www.who.int\/denguecontrol\/control_strategies\/en\/"},{"key":"680_CR83","unstructured":"Centers for Disease Control and Prevention (U.S.), National Center for Emerging and Zoonotic Infectious Diseases (U.S.), Pan American Health Organization. Preparedness and response for Chikungunya virus introduction in the Americas [Internet]. Washington, DC: Pan American Health Organization\u202f: CDC, Center for Disease Control and Prevention; 2011 [cited 2016 Jun 26]. Available from: http:\/\/new.paho.org\/hq\/index.php?option=com_docman&task=doc_download&gid=16984&Itemid"},{"key":"680_CR84","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.antiviral.2015.06.003","volume":"120","author":"E McSweegan","year":"2015","unstructured":"McSweegan E, Weaver SC, Lecuit M, Frieman M, Morrison TE, Hrynkow S. The global virus network: challenging chikungunya. Antiviral Res. 2015;120:147\u201352.","journal-title":"Antiviral Res"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-017-0680-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11882-017-0680-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-017-0680-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:06:13Z","timestamp":1744149973000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11882-017-0680-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":84,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["680"],"URL":"https:\/\/doi.org\/10.1007\/s11882-017-0680-7","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"24 February 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Drs. Mathew, Ganapati, Jayakanthan, Nair, Gupta, Chebbi, Mandal, and Danda declare no conflicts of interest relevant to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"13"}}